Cannabis Bioscience International Holdings, Inc. (CBIH) stock
CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026Market cap $2.33MP/E –Yield –
Cannabis Bioscience International operating margin
Operating margin is operating income as a percentage of revenue.
Cannabis Bioscience International's operating margin for the twelve months ending Feb 28, 2026 was -322.6%. For fiscal 2025 it was -139.1%, against -195.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | May 31, 2025 | -139.1% | +56.3 |
| FY2024 | May 31, 2024 | -195.4% | +115.0 |
| FY2023 | May 31, 2023 | -310.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -832.3% | +33.2 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -180.0% | −99.7 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -309.0% | −254.5 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -385.9% | −346.9 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -865.5% | −426.2 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -80.3% | +68.0 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -54.6% | +188.2 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -39.1% | +553.2 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -439.3% | +116.5 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -148.3% | +74.1 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -242.8% | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -592.3% | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -555.8% | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -222.3% | – |
See a number that looks wrong?